Literature DB >> 20181791

Serum phospholipid docosahexaenonic acid is associated with cognitive functioning during middle adulthood.

Matthew F Muldoon1, Christopher M Ryan, Lei Sheu, Jeffrey K Yao, Sarah M Conklin, Stephen B Manuck.   

Abstract

Existing evidence links greater dietary intake of fish and (n-3) PUFA to better early brain development and lowered risk of cognitive disorders in late life. The mechanisms for these associations remain unclear and may be related to specific (n-3) fatty acids and may concern cognitive function generally rather than only early brain development and age-related cognitive dysfunction. In this investigation, we tested potential associations between (n-3) fatty acids in serum phospholipids and major dimensions of cognitive functioning in mid-life adults. Participants were 280 community volunteers between 35 and 54 y of age, free of major neuropsychiatric disorders, and not taking fish oil supplements. Dietary biomarkers were alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenonic acid (DHA) in serum phospholipids measured using GC. Five major dimensions of cognitive functioning were assessed with a 75-min battery of neuropsychological tests. In covariate adjusted regression models, higher DHA (mol %) was related to better performance on tests of nonverbal reasoning and mental flexibility, working memory, and vocabulary (P <or= 0.05). These associations were generally linear. Associations between DHA and nonverbal reasoning and working memory persisted with additional adjustment for participant education and vocabulary scores (P <or= 0.05). Neither EPA nor ALA was notably related to any of the 5 tested dimensions of cognitive performance. Among the 3 key (n-3) PUFA, only DHA is associated with major aspects of cognitive performance in nonpatient adults <55 y old. These findings suggest that DHA is related to brain health throughout the lifespan and may have implications for clinical trials of neuropsychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20181791      PMCID: PMC2838625          DOI: 10.3945/jn.109.119578

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  46 in total

1.  Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients.

Authors:  J K Yao; S Leonard; R D Reddy
Journal:  Schizophr Res       Date:  2000-03-16       Impact factor: 4.939

2.  Fish consumption and cognitive decline with age in a large community study.

Authors:  Martha Clare Morris; Denis A Evans; Christine C Tangney; Julia L Bienias; Robert S Wilson
Journal:  Arch Neurol       Date:  2005-10-10

Review 3.  In vivo imaging of fatty acid incorporation into brain to examine signal transduction and neuroplasticity involving phospholipids.

Authors:  S I Rapoport; D Purdon; H U Shetty; E Grange; Q Smith; C Jones; M C Chang
Journal:  Ann N Y Acad Sci       Date:  1997-05-30       Impact factor: 5.691

4.  Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study.

Authors:  Ernst J Schaefer; Vanina Bongard; Alexa S Beiser; Stefania Lamon-Fava; Sander J Robins; Rhoda Au; Katherine L Tucker; David J Kyle; Peter W F Wilson; Philip A Wolf
Journal:  Arch Neurol       Date:  2006-11

Review 5.  Omega-3 fatty acids and mood disorders.

Authors:  Gordon Parker; Neville A Gibson; Heather Brotchie; Gabriella Heruc; Anne-Marie Rees; Dusan Hadzi-Pavlovic
Journal:  Am J Psychiatry       Date:  2006-06       Impact factor: 18.112

6.  Cognitive and physiological effects of Omega-3 polyunsaturated fatty acid supplementation in healthy subjects.

Authors:  G Fontani; F Corradeschi; A Felici; F Alfatti; S Migliorini; L Lodi
Journal:  Eur J Clin Invest       Date:  2005-11       Impact factor: 4.686

7.  Improvement of spatial cognition with dietary docosahexaenoic acid is associated with an increase in Fos expression in rat CA1 hippocampus.

Authors:  Yoko Tanabe; Michio Hashimoto; Kozo Sugioka; Megumi Maruyama; Yoshimi Fujii; Rika Hagiwara; Toshiko Hara; Shahdat Md Hossain; Osamu Shido
Journal:  Clin Exp Pharmacol Physiol       Date:  2004-10       Impact factor: 2.557

8.  Nonlinear relations of blood pressure to cognitive function: the Baltimore Longitudinal Study of Aging.

Authors:  Shari R Waldstein; Paul P Giggey; Julian F Thayer; Alan B Zonderman
Journal:  Hypertension       Date:  2005-02-07       Impact factor: 10.190

9.  Infant cerebral cortex phospholipid fatty-acid composition and diet.

Authors:  J Farquharson; F Cockburn; W A Patrick; E C Jamieson; R W Logan
Journal:  Lancet       Date:  1992-10-03       Impact factor: 79.321

10.  Omega-3 fatty acid treatment and T(2) whole brain relaxation times in bipolar disorder.

Authors:  Fuyuki Hirashima; Aimee M Parow; Andrew L Stoll; Christina M Demopulos; Karen E Damico; Michael L Rohan; Justin G Eskesen; Chun S Zuo; Bruce M Cohen; Perry F Renshaw
Journal:  Am J Psychiatry       Date:  2004-10       Impact factor: 18.112

View more
  29 in total

1.  Low-level mercury, omega-3 index and neurobehavioral outcomes in an adult US coastal population.

Authors:  Caterina Vacchi-Suzzi; Roxanne Karimi; Danielle Kruse; Susan M Silbernagel; Keith E Levine; Diane S Rohlman; Jaymie R Meliker
Journal:  Eur J Nutr       Date:  2015-04-02       Impact factor: 5.614

2.  Association of fish oil supplement use with preservation of brain volume and cognitive function.

Authors:  Lori A Daiello; Assawin Gongvatana; Shira Dunsiger; Ronald A Cohen; Brian R Ott
Journal:  Alzheimers Dement       Date:  2014-06-18       Impact factor: 21.566

3.  Omega-3 dietary Fatty Acid status of healthy older adults in Tasmania, Australia: an observational study.

Authors:  J K Pittaway; L T Chuang; K D K Ahuja; J M Beckett; R H Glew; M J Ball
Journal:  J Nutr Health Aging       Date:  2015-05       Impact factor: 4.075

4.  Dodecyl creatine ester-loaded nanoemulsion as a promising therapy for creatine transporter deficiency.

Authors:  Gabriela Ullio-Gamboa; Kenea C Udobi; Sophie Dezard; Marla K Perna; Keila N Miles; Narciso Costa; Frédéric Taran; Alain Pruvost; Jean-Pierre Benoit; Matthew R Skelton; Pascale de Lonlay; Aloïse Mabondzo
Journal:  Nanomedicine (Lond)       Date:  2019-04-30       Impact factor: 5.307

5.  Blood pressure interacts with APOE ε4 to predict memory performance in a midlife sample.

Authors:  Lauren E Oberlin; Stephen B Manuck; Peter J Gianaros; Robert E Ferrell; Matthew F Muldoon; J Richard Jennings; Janine D Flory; Kirk I Erickson
Journal:  Neuropsychology       Date:  2015-03-02       Impact factor: 3.295

Review 6.  Long-chain omega-3 fatty acids and optimization of cognitive performance.

Authors:  Matthew F Muldoon; Christopher M Ryan; Jeffrey K Yao; Sarah M Conklin; Stephen B Manuck
Journal:  Mil Med       Date:  2014-11       Impact factor: 1.437

Review 7.  Omega-3 essential fatty acids modulate initiation and progression of neurodegenerative disease.

Authors:  R Palacios-Pelaez; Walter J Lukiw; Nicolas G Bazan
Journal:  Mol Neurobiol       Date:  2010-05-14       Impact factor: 5.590

8.  Omega-3 fatty acids moderate effects of physical activity on cognitive function.

Authors:  Regina L Leckie; Stephen B Manuck; Neha Bhattacharjee; Matthew F Muldoon; Janine M Flory; Kirk I Erickson
Journal:  Neuropsychologia       Date:  2014-05-09       Impact factor: 3.139

9.  Current evidence for the clinical use of long-chain polyunsaturated n-3 fatty acids to prevent age-related cognitive decline and Alzheimer's disease.

Authors:  P A Dacks; D W Shineman; H M Fillit
Journal:  J Nutr Health Aging       Date:  2013-03       Impact factor: 4.075

Review 10.  Behavioral experiences as drivers of oligodendrocyte lineage dynamics and myelin plasticity.

Authors:  Lyl Tomlinson; Cindy V Leiton; Holly Colognato
Journal:  Neuropharmacology       Date:  2015-09-28       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.